Cladribine in multiple sclerosis: pitfalls in a new treatment landscape

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo Hartung Hans-Peter Kurukulasuriya Nuwan C Greenberg Steven J Scaramozza Matthew

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis

By Muir Victoria J. Plosker Greg L.

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin Miller David H

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite

Multiple Sclerosis: Pathogenesis and Treatment

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 409-416

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite